Half-year report · Q2
6545.TEDINET S100UH14
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥5.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥224m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥60m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥228m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥271m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥72m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥228m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥66m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥143m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥131m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥34m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥143m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥34m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥3.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥3.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.2bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥2.4bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.5bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.4bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.6bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥162m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥379m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥197m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥167m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥15m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥60m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥3m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥61m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥104m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥26.93 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.59 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.37 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥26.25 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥23.99 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥6.21 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 41.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.0% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥236m |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.8bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥263m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥822m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥822m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥197m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥461m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥273m |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E33005-000Health Care Solution Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥156m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥772m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥772m |
| jpcrp040300-q2r_E33005-000Home Care Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥177m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥333m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 462
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes business combinations quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |